Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2026-01-23

Sanofi to seek approval of touted eczema drug despite mixed results

BioPharma Dive 2026-01-23

Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal

BioPharma Dive 2026-01-23

Congress eyes tackling healthcare consolidation

BioPharma Dive 2026-01-22

Investors load Corxel with $287M for a ‘differentiated’ obesity pill

BioPharma Dive 2026-01-22

Bristol Myers buys into Janux’s ‘masked’ T cell engagers

BioPharma Dive 2026-01-22

FDA lays out new path to speed development of multiple myeloma drugs

BioPharma Dive 2026-01-22

BioMarin vets form Mendra to ‘modernize’ rare disease drug development

BioPharma Dive 2026-01-21

Corvus shares nearly triple on positive data for eczema pill

BioPharma Dive 2026-01-21

J&J eyes $100B in sales amid gains for cancer, immune drugs

BioPharma Dive 2026-01-20

Valneva to withdraw Chikungunya vaccine from US amid safety woes

BioPharma Dive 2026-01-20

GSK to buy Rapt in $2.2B deal for food allergy drug

BioPharma Dive 2026-01-20

Moderna cancer vaccine holds up; IO Biotech considers a sale

BioPharma Dive 2026-01-20

Kailera’s Ron Renaud on how a China-linked startup can compete in obesity

BioPharma Dive 2026-01-20

The patient retention crisis is happening before enrollment even begins

BioPharma Dive 2026-01-20

When every day counts: Building CRO partnerships on a foundation of trust, care and precision

BioPharma Dive 2026-01-16

Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading

BioPharma Dive 2026-01-16

On biotech’s biggest stage, renewed excitement gets a stress test

BioPharma Dive 2026-01-15

Trump unveils healthcare affordability plan

BioPharma Dive 2026-01-15

Tecvayli tops standard drugs in early multiple myeloma, J&J says

BioPharma Dive 2026-01-15

Oxford Biomedica confirms takeover talks with biotech investor EQT

-78 / 8